[Malignant mesothelioma of the peritoneum. Case report].
It is reported about a case of an advanced malign mesothelioma of the peritoneum. After a palliative operation the patient was treated for 3 years combined-cytostatically with cyclophosphamide, methotrexate, 5-fluororacil and vincristin. The patient has been free of symptoms of tumours for 4 years. Possible variants of therapy are discussed because of the rareness of the tumour and the therapeutic problems resulting from it.
D000328:Adult; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D003037:Cobalt Radioisotopes / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D008654:Mesothelioma / Q000188:drug therapy* / Q000532:radiotherapy; D008727:Methotrexate / Q000008:administration & dosage; D010534:Peritoneal Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy; D011867:Radioisotope Teletherapy; D014750:Vincristine / Q000008:administration & dosage
D000970:Antineoplastic Agents; D003037:Cobalt Radioisotopes; D014750:Vincristine; D003520:Cyclophosphamide; D005472:Fluorouracil; D008727:Methotrexate
Das maligne Mesotheliom des Peritoneums. Kasuistische Mitteilung.